Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-7772
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy ; volume:26 ; number:9 ; day:28 ; month:6 ; year:2021 ; pages:1729-1735 ; date:9.2021
International journal of clinical oncology ; 26, Heft 9 (28.6.2021), 1729-1735, 9.2021
- Urheber
-
Aydh, Abdulmajeed
Mori, Keiichiro
D'Andrea, David
Motlagh, Reza Sari
Abufaraj, Mohammad
Pradere, Benjamin
Mostafaei, Hadi
Laukhtina, Ekaterina
Quhal, Fahad
Karakiewicz, Pierre I.
Luzzago, Stefano
Briganti, Alberto
Trinh, Quoc-Dien
Parizi, Mehdi Kardoust
Tilki, Derya
Enikeev, Dmitry V.
Shariat, Shahrokh F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10147-021-01952-6
- URN
-
urn:nbn:de:101:1-2021110417544465282724
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aydh, Abdulmajeed
- Mori, Keiichiro
- D'Andrea, David
- Motlagh, Reza Sari
- Abufaraj, Mohammad
- Pradere, Benjamin
- Mostafaei, Hadi
- Laukhtina, Ekaterina
- Quhal, Fahad
- Karakiewicz, Pierre I.
- Luzzago, Stefano
- Briganti, Alberto
- Trinh, Quoc-Dien
- Parizi, Mehdi Kardoust
- Tilki, Derya
- Enikeev, Dmitry V.
- Shariat, Shahrokh F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Der Einfluss von Äther und Penthrane auf die Serum-Eiweiss-Fraktionen Albumin, α1- Globulin [Alpha-Globulin], α2-Globulin, β-Globulin [Beta-Globulin], γ-Globulin [Gamma-Globulin]
Immunologische Schwangerschaftsquerschnittsuntersuchung der Serumproteine: Albumin, Gc- Globulin, Beta-1A/C-[Globulin] und Beta-1E-Globulin
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Der Einfluss von Äther und Penthrane auf die Serum-Eiweiss-Fraktionen Albumin, α1- Globulin [Alpha-Globulin], α2-Globulin, β-Globulin [Beta-Globulin], γ-Globulin [Gamma-Globulin]
Immunologische Schwangerschaftsquerschnittsuntersuchung der Serumproteine: Albumin, Gc- Globulin, Beta-1A/C-[Globulin] und Beta-1E-Globulin
Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
Der Einfluss von Äther und Penthrane auf die Serum-Eiweiss-Fraktionen Albumin, α1- Globulin [Alpha-Globulin], α2-Globulin, β-Globulin [Beta-Globulin], γ-Globulin [Gamma-Globulin]